Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 7498298 Monomethylvaline compounds capable of conjugation to ligands

Patent 7498298 was granted and assigned to Seagen on March, 2009 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Seagen
Seagen
0
Date Filed
November 5, 2004
0
Date of Patent
March 3, 2009
0
Patent Application Number
10983340
0
Patent Citations Received
‌
US Patent 12134610 Somatostatin subtype-2 receptor (SST2R) targeted therapeutics and uses thereof
0
‌
US Patent 12071485 Compositions and methods of treating facioscapulohumeral muscular dystrophy
0
‌
US Patent 12071621 Anti-transferrin receptor antibody-PMO conjugates for inducing DMD exon 44 skipping
0
‌
US Patent 12076371 Activatable cytokine polypeptides and methods of use thereof
0
‌
US Patent 12104156 Compositions and methods of treating facioscapulohumeral muscular dystrophy
0
‌
US Patent 12129306 Antibodies binding to STEAP-1
0
‌
US Patent 12134649 Anti-B7-H4 antibodies and immunoconjugates
0
‌
US Patent 11702473 Site-specific antibody-drug conjugates
0
‌
US Patent 11707532 Compositions and methods of treating muscle dystrophy
0
‌
US Patent 11712478 Compositions and methods of treating muscle atrophy and myotonic dystrophy
0
•••
Patent Inventor Names
Brian E. Toki
0
Peter D. Senter
0
Svetlana O. Doronina
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
7498298
0
Patent Primary Examiner
‌
Andrew D. Kosar
0

Find more entities like US Patent 7498298 Monomethylvaline compounds capable of conjugation to ligands

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.